US equities
|
MU
$1,081.60
▲+3.45%
SNDK
$1,732.20
▲+4.32%
NVDA
$237.01
▼-0.93%
AMD
$642.79
▼-1.02%
SPCX
$168.94
▼-1.73%
INTC
$113.30
▲+0.71%
TSLA
$375.49
▼-1.36%
AAPL
$335.06
▲+0.43%
MU
$1,081.60
▲+3.45%
SNDK
$1,732.20
▲+4.32%
NVDA
$237.01
▼-0.93%
AMD
$642.79
▼-1.02%
SPCX
$168.94
▼-1.73%
INTC
$113.30
▲+0.71%
TSLA
$375.49
▼-1.36%
AAPL
$335.06
▲+0.43%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Latest News about NASDAQ:YMAB
Recent news which mentions NASDAQ:YMAB
Investing in Oncology: 4 Companies Driving Cancer Treatment Innovation
April 09, 2025
Tickers
CADL
DAWN
YMAB
Tags
NASDAQ:YMAB
NASDAQ:DAWN
NASDAQ:CADL
From
News Direct
YMAB Stock Earnings: Y-mAbs Therapeutics Misses EPS, Misses Revenue for Q2 2024
August 12, 2024
Tickers
YMAB
Tags
YMAB
Earnings Reports
NASDAQ:YMAB
From
InvestorPlace
YMAB Stock Earnings: Y-mAbs Therapeutics Misses EPS, Misses Revenue for Q1 2024
May 07, 2024
Tickers
YMAB
Tags
Market News
NASDAQ:YMAB
Earnings Reports
From
InvestorPlace